You are here

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Sector-12, Chandigarh, 160 012 India
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
42-72 days
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. Healthy infants aged 6 weeks (42-72 days) at time of enrolment

2. Available for the entire study period

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

1. Previous vaccination with pneumococcal, diphtheria, tetanus, pertussis or Hib vaccines

2. A previous anaphylactic reaction to any vaccine or vaccine-related component

3. Contraindication to vaccination with pneumococcal, Hib, diphtheria, tetanus,
pertussis, polio, hepatitis B or measles vaccines

NCT00452790
Pfizer
Completed
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Pneumococcal Infections
NCT00276107
All Genders
Pneumococcal Infections
NCT00488826
All Genders
Pneumococcal Infections
NCT00452790
All Genders
0+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now